Skip to main content
Fig. 2 | Cardio-Oncology

Fig. 2

From: Discovery of plasma proteins and metabolites associated with left ventricular cardiac dysfunction in pan-cancer patients

Fig. 2

Plasma protein dysregulation in left ventricular dysfunction. A Principal component analysis of proteomics analysis for cancer survivors with cancer therapy-related cardiac dysfunction (n = 10, blue) versus without (n = 40, red). B Differentially expressed proteins (P < 0.05) from affinity proteomics analysis in patients with LVD versus control. C Heatmap correlating cardiovascular proteins associated with NT-proBNP (P < 0.05)

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us